Jodie Pope Morrison - Jun 26, 2024 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Jodie Pope Morrison
Stock symbol
VERV
Transactions as of
Jun 26, 2024
Transactions value $
$0
Form type
4
Date filed
6/28/2024, 07:45 AM
Previous filing
Mar 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Award $0 +268K $0.00 268K Jun 26, 2024 Common Stock 268K $5.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date of the option is the grant date. The shares of common stock underlying the option are scheduled to vest in equal monthly installments through June 26, 2027, subject to the Reporting Person's continued service as a director.